Renal Effects of Aldosterone
Renal Effects of Aldosterone
批准号:
10266000
负责人:
David H Ellison
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2022-06-30
关键词:
Addison&aposs diseaseAddressAdrenal GlandsAftercareAldosteroneAldosterone AntagonistsBindingBiological MarkersBlood PressureBrainCYP11B2 geneCandidate Disease GeneCardiovascular DiseasesCarrier ProteinsCell NucleusCellsConsumptionDietDiseaseDistalDistal convoluted renal tubule structureDoxycyclineDuct (organ) structureDuctal Epithelial CellEFRACEffectivenessElectrolytesEpithelialEpithelial CellsExcretory functionExhibitsFundingGenesGeneticGenetic TranscriptionGlucocorticoidsGoalsHeart failureHomeostasisHormonesHumanHyperaldosteronismHypertensionHypotensionInfusion proceduresKCNJ1 geneKidneyKnock-outKnockout MiceKnowledgeLabelLeadLifeMeasuresMediatingMediator of activation proteinMetabolicMineralocorticoid ReceptorMineralocorticoidsMusNephronsOrganPathway interactionsPatientsPerinatal mortality demographicsPharmaceutical PreparationsPhenotypePhosphotransferasesPhysiologyPlasmaPopulationPotassiumPotassium ChannelProcessProductionProtein AnalysisProteinsReceptor ActivationRegulationReportingResearch PersonnelResistanceRoleSLC11A2 geneSLC12A3 geneSecondary HypertensionSerumSignal TransductionSiteSodiumSodium ChannelSodium ChlorideTestingTherapeuticTissuesTranscriptTranslatingVeteransWaterWhole-Cell RecordingsWorkZona Glomerulosadesigndietary saltdifferential expressionepithelial Na+ channelexosomeexperimental studyfightinghyperkalemiain vivonovelnovel strategiespatch clampreceptorresponsesalt intakeside effectsteroid hormonethiazidetranscriptometranscriptome sequencingurinarywasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this work is to determine how aldosterone causes cardiovascular disease, including
hypertension and heart failure. Mice in which the mineralocorticoid receptor can be deleted in
the kidney only will be used to examine aldosterone's role in signaling. These mice exhibit
diminished sodium flux through both the thiazide-sensitive NaCl cotransporter and the epithelial
sodium channel. Yet transport via the former is fully normalized when the mice are placed on
low potassium diet, indicating that sodium channel stimulation is the major direct effect of
aldosterone. The proposed experiments will test whether mineralocorticoid receptors along the
second part of the distal convoluted tubule, known as the DCT2, modulate sodium chloride
transport, but do so by occupancy with glucocorticoids, rather than by aldosterone. This will be
done by comparing effects of deleting the aldosterone synthase gene, which leads to deficient
aldosterone production, with the effects of deleting the mineralocorticoid receptor. The activity of
the sodium channel will be measured using patch clamp and whole cell recording and the
activity of the thiazide-sensitive NaCl cotransporter will be assessed using thiazide testing and
phosphor-protein analysis. If channel transport activity is low in the receptor knockout, but not
the synthase knockout, this will support the hypothesis.
In a second aim, novel mediators of aldosterone signaling will be sought. We will dissect
collecting ducts from mice with and without mineralocorticoid receptors, and consuming diets of
varied electrolyte content. These collecting ducts will be subjected to RNAseq, to determine
transcriptional differences that may underlie aldosterone effects. We will compare the transcripts
differentially expressed in high aldosterone states versus those absent in mice with low
aldosterone or lacking mineralocorticoid receptors. We will then select candidate genes to be
tested using cultured epithelial cells, and ultimately in vivo. We will seek proteins that are
essential for stimulating sodium channels under high aldosterone conditions.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Triphenyl{(E)-4-[4-(phenyldiazenyl)phenyl]-4H-1,2,4-triazol-1-yl}boron.
三苯基{(E)-4-[4-(苯基二氮烯基)苯基]-4H-1,2,4-三唑-1-基}硼。
DOI:
10.1107/s1600536809036071
发表时间:
2009
期刊:
Acta crystallographica. Section E, Structure reports online
影响因子:
--
作者:
[Urakami,Daisuke, Inoue,Katsuya, Hayami,Shinya]
通讯作者:
Hayami,Shinya
DOI:
10.1056/nejmra1313341
发表时间:
2015-07-02
期刊:
The New England journal of medicine
影响因子:
--
作者:
[Gumz ML, Rabinowitz L, Wingo CS]
通讯作者:
Wingo CS
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-004
-
批准号:10198073
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: